Galapagos Logo

Galapagos

Activités professionnelles, scientifiques et techniques

À propos de l'entreprise
Offres d'emploi0

At Galapagos we discover and develop molecules for medicines with novel modes of action. Innovative medicines that can change people’s lives. We not only want to develop them. We aim to deliver them to patients, too.

Our people are our biggest strength. We work with professionals that excel in what they are good at. With our dramatic growth in clinical programs, we wish to recruit the best experts in drug development in Europe. All disciplines, many positions.

People in Clinical Operations, Biometrics, Medical Affairs, Medical Science, Clinical Pharmacology, Chemical manufacturing, Project Management, Quality Monitoring, etc. We are looking for experienced, open-minded and ambitious candidates, ready to make a difference in a very dynamic working environment. People who dare to think big. You?

Galapagos (Euronext & NASDAQ: GLPG) is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Our pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications.

The Galapagos group, including fee-for-service subsidiairy Fidelta, has approximately 550 employees, operating from its Mechelen, Belgium headquarters and facilities in The Netherlands, France and Croatia. 

Jusqu'à 500Salariés
1999Année de fondation

Coordonnées

Site web

www.glpg.com